help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2007-0014
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stienstra, R.
Right arrow Articles by Müller, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stienstra, R.
Right arrow Articles by Müller, M.
Endocrinology Vol. 148, No. 6 2753-2763
Copyright © 2007 by The Endocrine Society

Peroxisome Proliferator-Activated Receptor {alpha} Protects against Obesity-Induced Hepatic Inflammation

Rinke Stienstra, Stéphane Mandard, David Patsouris, Cathy Maass, Sander Kersten and Michael Müller

Nutrition, Metabolism and Genomics Group (R.S., S.M., D.P., S.K., M.M.), Division of Human Nutrition, Wageningen University, 6700 EV Wageningen, The Netherlands; Nutrigenomics Consortium (R.S., S.K., M.M.), Wageningen Center of Food Sciences, 6709 PA Wageningen, The Netherlands; and Department of Pathology (C.M.), Radboud University Nijmegen Medical Center, 6500 HB Nijmegen, The Netherlands

Address all correspondence and requests for reprints to: Michael Müller, Ph.D., Division of Human Nutrition, Wageningen University, P.O. Box 8129, 6700 EV Wageningen, The Netherlands. E-mail: michael.muller{at}wur.nl.

Recently it has become evident that obesity is associated with low-grade chronic inflammation. The transcription factor peroxisome proliferator-activated receptor {alpha} (PPAR{alpha}) has been shown to have a strong antiinflammatory action in liver. However, the role of PPAR{alpha} in obesity-induced inflammation is much less clear. Therefore, the aim of our study was to determine whether PPAR{alpha} plays a role in obesity-induced hepatic inflammation. To induce obesity, wild-type sv129 and PPAR{alpha}–/– mice were exposed to a chronic high-fat diet (HFD), using a low-fat diet (LFD) as control. In wild-type mice, HFD significantly increased the hepatic and adipose expression of numerous genes involved in inflammation. Importantly, this effect was amplified in PPAR{alpha}–/– mice, suggesting an antiinflammatory role of PPAR{alpha} in liver and adipose tissue. Further analysis identified specific chemokines and macrophage markers, including monocyte chemotactic protein 1 and F4/80+, that were elevated in liver and adipose tissue of PPAR{alpha}–/– mice, indicating increased inflammatory cell recruitment in the knockout animals. When all groups of mice were analyzed together, a significant correlation between hepatic triglycerides and expression of inflammatory markers was observed. Many inflammatory genes that were up-regulated in PPAR{alpha}–/– livers by HFD were down-regulated by treatment with the PPAR{alpha} ligand Wy-14643 under normal nonsteatotic conditions, either in vivo or in vitro, suggesting an antiinflammatory effect of PPAR{alpha} that is independent of reduction in liver triglycerides. In conclusion, our results suggest that PPAR{alpha} protects against obesity-induced chronic inflammation in liver by reducing hepatic steatosis, by direct down-regulation of inflammatory genes, and by attenuating inflammation in adipose tissue.




This article has been cited by other articles:


Home page
ReproductionHome page
P J Williams, N Marten, V Wilson, J C Litten-Brown, A M Corson, L Clarke, M E Symonds, and A Mostyn
Influence of birth weight on gene regulators of lipid metabolism and utilization in subcutaneous adipose tissue and skeletal muscle of neonatal pigs
Reproduction, September 1, 2009; 138(3): 609 - 617.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
V. J. Vieira, R. J. Valentine, K. R. Wilund, N. Antao, T. Baynard, and J. A. Woods
Effects of exercise and low-fat diet on adipose tissue inflammation and metabolic complications in obese mice
Am J Physiol Endocrinol Metab, May 1, 2009; 296(5): E1164 - E1171.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
E. M. van Schothorst, A. Bunschoten, P. Schrauwen, R. P. Mensink, and J. Keijer
Effects of a high-fat, low- versus high-glycemic index diet: retardation of insulin resistance involves adipose tissue modulation
FASEB J, April 1, 2009; 23(4): 1092 - 1101.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
G. Bryzgalova, L. Lundholm, N. Portwood, J.-A. Gustafsson, A. Khan, S. Efendic, and K. Dahlman-Wright
Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed mice
Am J Physiol Endocrinol Metab, October 1, 2008; 295(4): E904 - E912.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
N. Anderson and J. Borlak
Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis
Pharmacol. Rev., September 1, 2008; 60(3): 311 - 357.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. A. Gyamfi, L. He, S. W. French, I. Damjanov, and Y.-J. Y. Wan
Hepatocyte Retinoid X Receptor {alpha}-Dependent Regulation of Lipid Homeostasis and Inflammatory Cytokine Expression Contributes to Alcohol-Induced Liver Injury
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 443 - 453.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society